MTOR and squamous cell carcinoma of penis: Conversely, PeIN had a lower percentage of cases with positive nuclear p-mTOR immunoexpression in comparison to primary PSCC cases (11/58; 19% vs. 64/239; 27%), however this was not significant (p = 0.2192, X2 test).